Your session is about to expire
← Back to Search
ivAED™ Device for Infusion Alarm Reduction
N/A
Recruiting
Led By J. Perrin Cobb, MD
Research Sponsored by Herrick Medical LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up patients will participate in the study from the time of enrollment in the icu for up to 3 days
Awards & highlights
Study Summary
This trial tests the effectiveness of two different IV infusion pumps to reduce air bubbles and the alarm they can trigger.
Who is the study for?
This trial is for adult patients in the Surgical ICU receiving IV infusions who, or whose surrogates, have given written consent. It excludes those who haven't consented, children under 18 years old, pregnant individuals, and prisoners.Check my eligibility
What is being tested?
The study tests if the ivAED device can reduce 'air-in-line' alarms during IV infusion by comparing two pumps: Braun Infusomat Space P and Becton-Dickenson Alaris model 8100 (current standard at Keck Hospital).See study design
What are the potential side effects?
Since this trial involves a device to improve IV infusion rather than a drug, traditional side effects are not applicable. However, there may be technical issues with the device that could affect infusion accuracy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ patients will participate in the study from the time of enrollment in the icu for up to 3 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~patients will participate in the study from the time of enrollment in the icu for up to 3 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Disruption of nursing workflow, measured as number of minutes required to attend to alarm and restore infusion flow.
Number of air-in-line IV infusion alarms (as detected by the IV infusion pump)
Secondary outcome measures
Cost
Loss of Infusate
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Standard pump and ivEAD tubingExperimental Treatment1 Intervention
ivEAD tubing
Group II: Braun Infusomat Pump and ivEAD tubingExperimental Treatment1 Intervention
ivEAD tubing
Group III: Braun Infusomat Pump and standard tubingActive Control1 Intervention
Standard tubing
Group IV: Standard infusion pump and standard tubingActive Control1 Intervention
Standard tubing
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaOTHER
906 Previous Clinical Trials
1,596,076 Total Patients Enrolled
Herrick Medical LLCLead Sponsor
1 Previous Clinical Trials
24 Total Patients Enrolled
J. Perrin Cobb, MDPrincipal InvestigatorUniversity of Southern California
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger